IONQ
IonQ, Inc.
There isn't enough reported data to score IONQ yet.
OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
IONQ Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Weak | |
| Unavailable |
IONQ's revenue is currently healthy, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
IONQ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 33x | $30.86 | — |
| Cheap | 86x | $80.61 | +161% |
| Fair | 126x | $119 | +285% |
| Expensive | 147x | $138 | +349% |
Historical ranges are pointers, not guarantees.
IONQ has the edge over OSCR in the historical PE scenario, which offers more potential upside but is not a forecast.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
IONQ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect IONQ's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
IONQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.94 | +$6.31 |
| Q2 2026 | -$3.99 | -$1.96 |
| Q1 2026 | $0.39 | +$1.90 |
| Q4 2025 | -$1.82 | -$0.26 |
| Q3 2025 | -$5.37 | -$4.56 |
| Q2 2025 | -$2.03 | -$1.24 |
| Q1 2025 | -$1.51 | -$0.68 |
| Q4 2024 | -$1.56 | -$0.78 |
IONQ has returned to profit: it earned $0.94 per share over the past year, after losing money the year before.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over IONQ on earnings, with more consistent year-over-year improvement.
IONQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $173.8M | +336% |
| Q2 2026 | $80.1M | +287% |
| Q1 2026 | $64.7M | +755% |
| Q4 2025 | $61.9M | +429% |
| Q3 2025 | $39.9M | +222% |
| Q2 2025 | $20.7M | +82% |
| Q1 2025 | $7.6M | -0.2% |
| Q4 2024 | $11.7M | +92% |
IONQ's revenue is recovering but still below its 2022 peak: $174M last quarter, up 336% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -249% | +174 points |
| Q2 2026 | -421% | +355 points |
| Q1 2026 | -420% | +580 points |
| Q4 2025 | -369% | +292 points |
| Q3 2025 | -423% | +5.1 points |
| Q2 2025 | -776% | -346 points |
| Q1 2025 | -1000% | -303 points |
| Q4 2024 | -662% | +230 points |
IONQ's operating margin was −249% last quarter, up 174 points from the same quarter a year ago, near the top of its range since 2021.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR's revenue has grown year over year every quarter since early 2021: $5.1B last quarter, up 72% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over IONQ on profitability, with a higher operating margin.
IONQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$331.9M | -$204.7M |
| Q2 2026 | -$114M | -$60.2M |
| Q1 2026 | -$159.4M | -$124.1M |
| Q4 2025 | -$83.3M | -$40.3M |
| Q3 2025 | -$127.2M | -$104.2M |
| Q2 2025 | -$53.8M | -$19.7M |
| Q1 2025 | -$35.3M | -$11.7M |
| Q4 2024 | -$43M | -$9.2M |
IONQ has burned cash in almost every quarter: −$689M over the past year, against −$259M the year before.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over IONQ on cash generation, producing positive trailing cash flow while its opponent burns cash.
IONQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9% | +33.2M shares |
| 1 year | +60% | +150M shares |
| 3 years | +99% | +199M shares |
| 5 years | +108% | +208M shares |
IONQ has 401M diluted shares, up 60% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over IONQ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
IONQ Net Leverage
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
IONQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.7 | Neutral |
| Stochastic | 22.3 | Neutral |
IONQ's weekly RSI is 41 (neutral) and its Stochastic is 22 (neutral).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
IONQ PE vs Technology Sector
| Metric | IONQ | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 28x | 18% above |
IONQ is trading at 33x earnings, a 18% premium to the Technology sector's median of 28x, though its earnings don't support one.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR has the edge over IONQ on valuation relative to its sector.
IONQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.7 | 13% below |
| 20 week MA | $38.6 | 20% below |
| 50 week MA | $42.4 | 27% below |
| 100 week MA | $42.2 | 27% below |
| 200 week MA | $26.8 | 15% above |
IONQ has fallen below most of its moving averages, though it's still 15% above its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over IONQ on trend strength, trading above more of its moving averages.
IONQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $11.0 | $17.9 | +62% |
| 2022 | $17.9 | $3.30 | -82% |
| 2023 | $3.30 | $12.4 | +275% |
| 2024 | $12.4 | $45.5 | +267% |
| 2025 | $45.5 | $46.0 | +1.1% |
| 2026 YTD | $46.0 | $30.9 | -33% |
IONQ's yearly returns have swung widely, from +275% in 2023 to −82% in 2022. It's down 33% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over IONQ on returns for 2026, with the stronger performance.